Net Income

As KP Tissue prepares to release Q4 2025 results, all eyes are on Kruger Products' performance after a year of major strategic investments and expansion.

A partnership between NSA Labs and Proscia is slashing study times for brain research, showing how digital platforms are key to finding new therapies faster.

A major patent deal shields Esperion's flagship drugs from generics, securing future revenue but delaying cheaper options for millions of patients.

Beyond insurance, Superior HealthPlan invested nearly $1.2 million in 2025, opening a Uvalde health center and tackling youth mental health across Texas.

Sifted's new agentic AI platform acts as an 'always-on analyst,' promising to slash shipping costs and complexity by making autonomous, data-driven moves.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Pangaea Logistics declared a $0.05 dividend, but what does this move signal about the company's health and the broader dry bulk market's future?

An Innventure company proves its technology can turn real-world plastic trash into valuable chemicals, but can it navigate the path to commercialization?

Gaxos.ai secures a deal with ByteDance's BytePlus, gaining access to elite AI video models to challenge giants in the booming creator content market.

Tampa's The Cake Girl marks 10 years of success. Founder Kristina Lavallee's journey from a food truck to a national dessert authority is a masterclass in grit.

An OTC-listed company's $11.7M deal for a Texas power plant highlights a critical trend: the race to secure private energy for the AI revolution.

Cyrano Therapeutics' CYR-064 shows promise in a Phase 2 study, potentially becoming the first approved drug for persistent post-viral smell loss.

Nakamoto Inc. acquires Bitcoin Magazine's parent and a key investment firm in an all-stock deal, raising questions about market influence and shareholder value.

Provident Bank hires industry veteran Joseph A. Tammaro, Jr. to head its Middle Market Lending, signaling a strategic move to capture regional market share.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

New research reveals a startling link between AI's excessive permissions and a surge in security breaches, forcing a rethink of enterprise trust and access.

New research reveals a startling mobile security gap, with 72% of firms facing incidents and 65% losing customers as AI and speed pressures add new risks.

With a bolstered balance sheet and a sharpened focus, Palatin Technologies is advancing two novel obesity drugs into clinical trials for rare genetic disorders.

Landmark study in JAMA Neurology shows BRIUMVI offers near-zero relapse rates and stable disability, reshaping long-term multiple sclerosis treatment.

At a key conference, DocGo's CEO will navigate financial headwinds while promoting a vision for proactive, tech-enabled healthcare delivery.